TP53 and neoplasm: Mechanistically, p53 LOF is associated with the upregulation of ECM components (e.g., fibronectin, extracellular matrix metalloproteinase inducer, and matrix metalloproteinases), and these changes are accompanied by invasion-metastasis and the inhibition of apoptosis in tumor cells [79,84].